EMD-25200
CryoEM structure of SARS-CoV-2 HexaPro spike in complex with S2-binding CV3-25
EMD-25200
Single-particle3.49 Å
Deposition: 25/10/2021Map released: 13/04/2022
Last modified: 13/04/2022
Sample Organism:
Homo sapiens,
Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 S-6P in complex with CV3-25
Deposition Authors: Chen Y
,
Huang R,
Pazgier M
Sample: SARS-CoV-2 S-6P in complex with CV3-25
Deposition Authors: Chen Y
,
Huang R,
Pazgier M
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern.
Li W ,
Chen Y ,
Prevost J ,
Ullah I,
Lu M ,
Gong SY ,
Tauzin A ,
Gasser R ,
Vezina D,
Anand SP,
Goyette G,
Chaterjee D,
Ding S,
Tolbert WD,
Grunst MW ,
Bo Y,
Zhang S,
Richard J ,
Zhou F,
Huang RK,
Esser L,
Zeher A ,
Cote M,
Kumar P,
Sodroski J,
Xia D,
Uchil PD,
Pazgier M ,
Finzi A,
Mothes W
(2022) Cell Rep , 38 , 110210 - 110210
,
Chen Y ,
Prevost J ,
Ullah I,
Lu M ,
Gong SY ,
Tauzin A ,
Gasser R ,
Vezina D,
Anand SP,
Goyette G,
Chaterjee D,
Ding S,
Tolbert WD,
Grunst MW ,
Bo Y,
Zhang S,
Richard J ,
Zhou F,
Huang RK,
Esser L,
Zeher A ,
Cote M,
Kumar P,
Sodroski J,
Xia D,
Uchil PD,
Pazgier M ,
Finzi A,
Mothes W
(2022) Cell Rep , 38 , 110210 - 110210
Grant Support:
- Other government: USUHS start-up fund (United States)